Several genetic markers that could help identify individuals at risk for developing acute kidney injury in the hospital setting have been discovered by researchers. The new research will be presented at ASN Kidney Week 2014. Utilizing new genetic analysis techniques, scientists pinpointed several markers associated with AKI-an increasingly prevalent surgical and hospital complication.
Collaborators from Yale University, Vanderbilt University, and the University of Western Ontario wanted to determine if they could identify patients who may have a higher genetic risk for develop AKI in the hospital. "This may uncover novel pathways to target for therapeutic interventions," said senior author Chirag R. Parikh, MD, PhD, FASN of Yale.
Until recently, analysis methods limited the scope of genetic AKI studies. "But technological progress in genotyping has opened the possibilities towards hypothesis-generating genomic screens and novel opportunities to explore polygenetic perspectives, now spanning a wide array of possible analyses falling under the term Genome-Wide Association Study (GWAS)," said Dr. Parikh.
"AKI is heterogenous disease and genetic studies need to be continued to fully capture the host risk," Dr. Parikh emphasized. "It is recommended that sequencing can be used as a complement to GWAS, to obtain a better map of the genetic variants in GWAS-significant genes or well-established candidate genes."
This study was supported by the National Institutes of Health NIH R01HL085757 and P30 DK079310 O'Brien Kidney Center Grant.
Study: "A Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms Conferring Risk for Acute Kidney Injury" (Abstract TH-OR028)
Disclosure information is available at
ASN Kidney Week 2014, the largest nephrology meeting of its kind, will provide a forum for more than 13,000 professionals to discuss the latest findings in kidney health research and engage in educational sessions related to advances in the care of patients with kidney and related disorders.
ASN Kidney Week 2014 will take place November 11-16, 2014, at the Pennsylvania Convention Center in Philadelphia, PA.
ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with nearly 15,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.